SLDB: Solid Biosciences Inc. Stock

by  •  • Comments Off on SLDB: Solid Biosciences Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 271.61
Enterprise Value ($M) 60.98
Book Value ($M) 294.46
Book Value / Share 3.80
Price / Book 0.92
NCAV ($M) 263.97
NCAV / Share 3.41
Price / NCAV 1.03

Profitability (mra)
Return on Invested Capital (ROIC) -0.44
Return on Assets (ROA) -0.56
Return on Equity (ROE) -0.66

Liquidity (mrq)
Quick Ratio 10.89
Current Ratio 10.89

Balance Sheet (mrq) ($M)
Current Assets 313.41
Assets 343.90
Liabilities 49.44
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -129.73
Net Income -124.70
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -100.01
Cash from Investing -16.09
Cash from Financing 122.44

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
05-15 13G/A Vestal Point Capital, LP 2.30 -37.37
05-12 13G Adage Capital Management, L.P. 8.68 283.63
04-17 13G/A Invus Global Management, LLC 9.60 97.81
02-25 13G Commodore Capital Lp 7.60
02-21 13D/A Perceptive Advisors Llc 15.60 72.10
02-21 13D/A Ra Capital Management, L.p.
02-21 13D/A BCLS SB Investco, LP
11-14 13G/A Flynn James E 0.00 -100.00
11-01 13G/A Millennium Management Llc 2.90 -44.53

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2025-03-06 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-06-03 317,486 1,114,845 28.48
2025-06-02 398,053 2,184,153 18.22
2025-05-30 139,847 791,182 17.68
2025-05-29 141,058 653,292 21.59

(click for more detail)

Similar Companies
SANA – Sana Biotechnology, Inc. SCPH – scPharmaceuticals Inc.
SDGR – Schrödinger, Inc. SNDX – Syndax Pharmaceuticals, Inc.
SPRO – Spero Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io